These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15956054)

  • 1. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice.
    O'Brien CA; Jilka RL; Fu Q; Stewart S; Weinstein RS; Manolagas SC
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E784-93. PubMed ID: 15956054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
    Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFalpha and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics.
    Dai JC; He P; Chen X; Greenfield EM
    Bone; 2006 Apr; 38(4):509-20. PubMed ID: 16316790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.
    Xing L; Carlson L; Story B; Tai Z; Keng P; Siebenlist U; Boyce BF
    J Bone Miner Res; 2003 Feb; 18(2):260-9. PubMed ID: 12568403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH.
    Ueno Y; Shinki T; Nagai Y; Murayama H; Fujii K; Suda T
    J Cell Biochem; 2003 Oct; 90(2):267-77. PubMed ID: 14505343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
    Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D and bone.
    Suda T; Ueno Y; Fujii K; Shinki T
    J Cell Biochem; 2003 Feb; 88(2):259-66. PubMed ID: 12520524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
    Lee SK; Gardner AE; Kalinowski JF; Jastrzebski SL; Lorenzo JA
    Bone; 2006 May; 38(5):678-85. PubMed ID: 16309985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N; Colla S; Morandi F; Rizzoli V
    Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis.
    Kishimoto Y; Fukumoto S; Nishihara S; Mizumura H; Hirai K; Teshima R
    Rheumatology (Oxford); 2004 Dec; 43(12):1496-503. PubMed ID: 15353610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated T lymphocytes support osteoclast formation in vitro.
    Horwood NJ; Kartsogiannis V; Quinn JM; Romas E; Martin TJ; Gillespie MT
    Biochem Biophys Res Commun; 1999 Nov; 265(1):144-50. PubMed ID: 10548505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of osteoclastogenesis by gap junction communication.
    Matemba SF; Lie A; Ransjö M
    J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck.
    Tsangari H; Findlay DM; Kuliwaba JS; Atkins GJ; Fazzalari NL
    Bone; 2004 Jul; 35(1):334-42. PubMed ID: 15207775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
    Wang L; Liu S; Quarles LD; Spurney RF
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
    J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclast development in immobilized bone is suppressed by parathyroidectomy in mice.
    Sakai A; Mori T; Sakuma-Zenke M; Takeda T; Nakai K; Katae Y; Hirasawa H; Nakamura T
    J Bone Miner Metab; 2005; 23(1):8-14. PubMed ID: 15616888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures.
    Abdallah BM; Stilgren LS; Nissen N; Kassem M; Jørgensen HR; Abrahamsen B
    Calcif Tissue Int; 2005 Feb; 76(2):90-7. PubMed ID: 15570403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone.
    Locklin RM; Khosla S; Turner RT; Riggs BL
    J Cell Biochem; 2003 May; 89(1):180-90. PubMed ID: 12682918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.